Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.30
Delayed Data
As of Apr 25
 +0.16 / +0.26%
Today’s Change
53.06
Today|||52-Week Range
66.80
+5.83%
Year-to-Date

Today’s Trading

Previous close62.14
Today’s open62.49
Day’s range62.25 - 62.93
Volume10,691,839
Average volume (3 months)10,053,355
Market cap$170.4B
Dividend yield3.02%
Data as of 04/25/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+0.62%
Earnings growth (next 5 years)+4.40%
Revenue growth (last year)+1.86%
P/E ratio44.2
Price/Sales4.15
Price/Book4.26

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+1.63+2.18%
PFEPfizer+0.02+0.06%
SNYSanofi+0.50+1.09%
ABBVAbbVie+0.44+0.68%
Data as of 04/25/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$0.84
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts


Search for Jobs